There is limited availability in NSW and Australia for quality and efficient cancer genetic services. We are dedicated to being a leader in this growing field of precision medicine and strive to improve access to these services within Australia. Many private pathology companies charge high prices for such services but we work with available Medicare rebate items to lower the cost for our patients and clients.
For more information on our Anatomical Pathology Cancer Genetic testing capabilities, please click here.
For more information on our Haematology Cancer Genetic testing capabilities, please click here.
SydPath offers an expanding suite of molecular diagnostic assays for cancer diagnosis.
Each tumour is different, driven by certain key mutations/genetic rearrangements, creating a “fingerprint” or profile. Targeted therapies for specific mutations can then be used to treat the cancer. Common practice is to classify the cancer by the organ of origin.
Tumours are now starting to be classified by their driver mutations, leading to more appropriately targeted therapies. The current handful of available biomarker assays can easily miss a driver mutation.
The Centre for Clinical Genomics (CCG) is a developing collaboration between the Garvan Institute of Medical Research and St Vincents’s Hospital Sydney Limited, utilising the latest sequencing technology, and world leading bioinformatics.
Without limiting its role to cancer, The CCG will:
For more detailed information on our Next Generation Sequencing testing services, please click here.
Meet our Pathologists here